Novo Nordisk Long-Term Investments 2012-2026 | NVO

Novo Nordisk long-term investments for the quarter ending March 31, 2026 were $0.351B, a 7.88% decline year-over-year.

  • Novo Nordisk long-term investments for 2025 were $0.38B, a 2.22% decline from 2024.
  • Novo Nordisk long-term investments for 2024 were $0.388B, a 60.75% increase from 2023.
  • Novo Nordisk long-term investments for 2023 were $0.241B, a 26.98% increase from 2022.

Novo Nordisk Long-Term Investments 2012-2026 | NVO

  • Novo Nordisk long-term investments for 2025 were $0.38B, a 2.22% decline from 2024.
  • Novo Nordisk long-term investments for 2024 were $0.388B, a 60.75% increase from 2023.
  • Novo Nordisk long-term investments for 2023 were $0.241B, a 26.98% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B